Catalog
APIs, intermediates, and finished formulations.
Search materials made in India, plus finished dosage forms we manufacture for pharma partners. Grade and documents are confirmed on request, not guessed in this list.
Loading the catalog…
Catalog
Search materials made in India, plus finished dosage forms we manufacture for pharma partners. Grade and documents are confirmed on request, not guessed in this list.
Loading the catalog…
69 products
50910-55-9
Pharmaceutical intermediate
97-97-2
Pharmaceutical intermediate
2568-30-1
Pharmaceutical intermediate
42019-78-3
Pharmaceutical intermediate
61718-80-7
Pharmaceutical intermediate
5911-08-0
Pharmaceutical intermediate
781-35-1
Pharmaceutical intermediate
19249-04-8
Pharmaceutical intermediate
6065-63-0
Pharmaceutical intermediate
42017-89-0
Active pharmaceutical ingredient · Fibrate (PPAR-α agonist) used for dyslipidemia
4826-71-5
Pharmaceutical intermediate
14597-26-3
Pharmaceutical intermediate
1603-79-8
Pharmaceutical intermediate
372-09-8
Pharmaceutical intermediate
105-56-6
Pharmaceutical intermediate
623-05-2
Pharmaceutical intermediate
51368-55-9
Pharmaceutical intermediate
1636-27-7
Pharmaceutical intermediate
30698-30-7
Pharmaceutical intermediate
161798-02-3
Pharmaceutical intermediate
99-40-1
Pharmaceutical intermediate
864070-44-0
Active pharmaceutical ingredient · SGLT2 inhibitor, type 2 diabetes
461432-26-8
Active pharmaceutical ingredient · SGLT2 inhibitor, type 2 diabetes
503612-47-3
Active pharmaceutical ingredient · Direct factor Xa inhibitor, oral anticoagulant
486460-32-6
Active pharmaceutical ingredient · DPP-4 inhibitor, type 2 diabetes · Salt form on request
366789-02-8
Active pharmaceutical ingredient · Direct factor Xa inhibitor, oral anticoagulant
274901-16-5
Active pharmaceutical ingredient · DPP-4 inhibitor, type 2 diabetes
287714-41-4
Active pharmaceutical ingredient · HMG-CoA reductase inhibitor (statin) for hypercholesterolemia · Salt form on request
66722-44-9
Active pharmaceutical ingredient · Selective β1-adrenergic blocker for hypertension and heart failure · Salt form on request
211914-51-1
Active pharmaceutical ingredient · Direct thrombin inhibitor, oral anticoagulant · Salt form on request
518048-05-0
Active pharmaceutical ingredient · HIV integrase inhibitor
155213-67-5
Active pharmaceutical ingredient · HIV protease inhibitor
136470-78-5
Active pharmaceutical ingredient · Nucleoside reverse transcriptase inhibitor (NRTI) for HIV
198904-31-3
Active pharmaceutical ingredient · HIV protease inhibitor
1051375-16-6
Active pharmaceutical ingredient · HIV integrase inhibitor
192725-17-0
Active pharmaceutical ingredient · HIV protease inhibitor
Dry-powder inhaler capsules 200/6 and 400/6 mcg
Finished formulations · Respiratory (asthma/COPD)
Tablets 10 mg; syrup
Finished formulations · Respiratory / allergy
Tablets 250/500 mg; IV infusion 200 mg/100 ml
Finished formulations · Anti-infective
Tablets 200–800 mg
Finished formulations · Neurology (epilepsy)
Granules for oral solution, 3 g sachet
Finished formulations · Anti-infective (UTI)
Oral syrups with ambroxol, terbutaline or levosalbutamol
Finished formulations · Respiratory (cough)
Tablets 400/600/800 mg
Finished formulations · Pain / anti-inflammatory
Tablets
Finished formulations · Pain / anti-inflammatory
Tablets; oral suspension 100 mg/5 ml
Finished formulations · Pain / analgesic
Tablets; syrup; also with montelukast
Finished formulations · Respiratory / allergy
Tablets
Finished formulations · CNS (antipsychotic)
Immediate-release and sustained-release tablets
Finished formulations · CNS (antipsychotic)
Extended-release tablets 500/1000 mg
Finished formulations · Cardiology (angina)
Tablets 5/10 mg
Finished formulations · Neurology (migraine)
Effervescent tablets 600 mg
Finished formulations · Respiratory (mucolytic)
Prefilled syringe 40 mg/0.8 ml
Finished formulations · Rheumatology
Capsules; also with clopidogrel
Finished formulations · Cardiology
IV vials 100/400 mg
Finished formulations · Oncology
Dry powder for injection, vials
Finished formulations · Anti-infective
Dry powder for injection, vials; also with sulbactam or tazobactam
Finished formulations · Anti-infective
Prefilled syringe 60 mg/ml
Finished formulations · Osteoporosis
Lotion
Finished formulations · Dermatology
Prefilled syringe 300 mcg
Finished formulations · Oncology supportive (neutropenia)
Gel, with allantoin
Finished formulations · Dermatology
Dry powder for injection, vials; also with sulbactam
Finished formulations · Anti-infective
Extended-release capsules
Finished formulations · Gastroenterology (IBD)
Extended-release tablets 500/750 mg; sustained-release tablets
Finished formulations · Diabetes
Lyophilised 40 mg vial
Finished formulations · Gastroenterology
Tablets 500/650/1000 mg; infusion
Finished formulations · Pain / analgesic
Dry powder for injection, vials
Finished formulations · Anti-infective
IV vials 100/500 mg
Finished formulations · Oncology
Prefilled syringe/pen 600 mcg/2.4 ml
Finished formulations · Osteoporosis
Lyophilised vials 150/440 mg
Finished formulations · Oncology